Looking to engage with our member community by contributing to ASAP’s content? Send your blog post, article draft, or idea to Michael Burke at mburke@strategic-alliances.org
Although tech and pharma alliances have some very different nuances, strategic thinking, trust, and conflict resolution are necessary to get that sweet taste of alliance success in either industry. Christina Neary and Alison Handley expanded on these themes in the latest ASAP webinar. Continue Reading
If your company is easy to deal with as a partner, you're more likely to deliver great results and attract new employees, partners, and customers. So how do you simplify the partner experience? Phil Sack explained in the latest Collaborative Connection Monthly webinar and roundtable. Continue Reading
A recent ASAP Roundtable surveyed biopharma alliance managers from around the Asia Pacific region on the most pressing issues they face. Managing stakeholders, finding talent, and ensuring good governance topped the list. But the APAC partnering boom highlighted some regional specifics too. Continue Reading
Trust is the foundation of any alliance. You need to build it between and within partner organizations early, and work hard to maintain it over time. Because once it's gone, so goes your alliance, in all likelihood, as was explained in ASAP's latest webinar. Continue Reading
In discovery-phase alliances, alliance managers need to have their eyes on the big picture and broader company strategy when working with scientists who are often too narrowly focused on short-term objectives. Three Takeda executives explained in an 2022 ASAP BioPharma Conference presentation. Continue Reading
Caroline Rader, Chris Black, Ken Marran, and Ryan Lenox brought ASAP BioPharma Conference took attendees behind the curtain of Merck's Big-Pharma-to-Big-Pharma alliances, which are responsible for major multibillion-dollar, market-moving drug candidates. Continue Reading
Communication is "job number one." Alliance manager are “communications cops” who function as “communications central,” making sure internal and partner stakeholders receive and deliver critical information pertaining to the partnership in a timely manner. Continue Reading
Jim Mullen of Editas Medicine delivered tips on dealing with “the Bermuda Triangle of contract issues”—decision rights, dispute resolution, and termination—in his ASAP BioPharma Conference keynote. When conflict arises, get agreement on the facts, but don't require a consensus decision. Continue Reading
What do biopharma alliance managers need to know about digital transformation? Microsoft's Elena Bonfiglioli outlined three things in her ASAP BioPharma Conference keynote: 1) culture that promotes privacy, 2) competencies, and 3) trust. Continue Reading
How do you continually improve your partnerships? Don't wait until something is broken to make adjustments, reward the people making improvements, discuss potential changes frequently, and use the ISO 44001 and 56002 standards in combination. The latest Collaborative Connection Monthly explains. Continue Reading
How do you develop therapies that will help capture part of the rare/orphan disease market that is expected to exceed $300 billion in 2030? It takes an ecosystem of seven players, explained Jeff Livingstone in his ASAP BioPharma Conference presentation last last month. Continue Reading
Influence is what helps build bridges when partners are at odds. “It is perhaps the hardest part of the job, but it is the part of the job that delivers the greatest value." The Rhythm of Business delivered a master class on the subject at the 2022 ASAP BioPharma Conference. Continue Reading
